home / stock / knsa / knsa message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: KNSA 22% v1,2M c12.73 f68,5M H13.55 | znewcar1 | investorshangout | 11/01/2021 10:46:33 PM |
No bueno. I guess $HGEN's lenzilumab is | DonDonDonDon | investorshub | 04/01/2021 11:24:49 PM |
It was recently discovered that the protein GM-CSF | DonDonDonDon | investorshub | 03/22/2021 2:17:19 PM |
PT= $30-40 (by or around March 31st) | Femto99 | investorshub | 02/26/2021 11:28:28 PM |
PDUFA Mar21 | Femto99 | investorshub | 02/10/2021 6:44:09 PM |
News, Short Squeeze, Breakout and More Instantly...
Kiniksa Pharmaceuticals Ltd. Company Name:
KNSA Stock Symbol:
NASDAQ Market:
2024-03-23 21:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-20 10:20:00 ET March 20, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies are involved in immuno-oncology, ...
– ARCALYST ® (rilonacept) Q4 2023 and full-year 2023 net product revenue of $71.2 million and $233.2 million, respectively – – ARCALYST 2024 net product revenue expected to be $360 - $380 million, representing ~59% year-over-year growth at the midpo...